ETBI
vs
S&P 500
ETBI
S&P 500
Over the past 12 months, ETBI has significantly outperformed S&P 500, delivering a return of +900% compared to the S&P 500's +16% growth.
Stocks Performance
ETBI vs S&P 500
Performance Gap
ETBI vs S&P 500
Performance By Year
ETBI vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Eastgate Biotech Corp
Glance View
Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2014-01-16. The firm produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The firm develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).
